These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 19098114)
1. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114 [TBL] [Abstract][Full Text] [Related]
2. Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension. Rasoul S; Carretero OA; Peng H; Cavasin MA; Zhuo J; Sanchez-Mendoza A; Brigstock DR; Rhaleb NE J Hypertens; 2004 Mar; 22(3):593-603. PubMed ID: 15076166 [TBL] [Abstract][Full Text] [Related]
3. N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats. González GE; Rhaleb NE; Nakagawa P; Liao TD; Liu Y; Leung P; Dai X; Yang XP; Carretero OA Clin Sci (Lond); 2014 Jan; 126(1):85-94. PubMed ID: 23834332 [TBL] [Abstract][Full Text] [Related]
4. Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension. Rhaleb NE; Peng H; Yang XP; Liu YH; Mehta D; Ezan E; Carretero OA Circulation; 2001 Jun; 103(25):3136-41. PubMed ID: 11425781 [TBL] [Abstract][Full Text] [Related]
5. Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. Castoldi G; di Gioia CR; Bombardi C; Perego C; Perego L; Mancini M; Leopizzi M; Corradi B; Perlini S; Zerbini G; Stella A Clin Sci (Lond); 2009 Oct; 118(3):211-20. PubMed ID: 20310083 [TBL] [Abstract][Full Text] [Related]
6. Peng H; Xu J; Yang XP; Kassem KM; Rhaleb IA; Peterson E; Rhaleb NE Can J Physiol Pharmacol; 2019 Aug; 97(8):753-765. PubMed ID: 30998852 [TBL] [Abstract][Full Text] [Related]
7. Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Yang F; Yang XP; Liu YH; Xu J; Cingolani O; Rhaleb NE; Carretero OA Hypertension; 2004 Feb; 43(2):229-36. PubMed ID: 14691195 [TBL] [Abstract][Full Text] [Related]
8. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Peng H; Carretero OA; Raij L; Yang F; Kapke A; Rhaleb NE Hypertension; 2001 Feb; 37(2 Pt 2):794-800. PubMed ID: 11230375 [TBL] [Abstract][Full Text] [Related]
10. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research. Liao TD; Yang XP; D'Ambrosio M; Zhang Y; Rhaleb NE; Carretero OA Hypertension; 2010 Feb; 55(2):459-67. PubMed ID: 20026760 [TBL] [Abstract][Full Text] [Related]
11. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension. Lin CX; Rhaleb NE; Yang XP; Liao TD; D'Ambrosio MA; Carretero OA Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1253-H1261. PubMed ID: 18641275 [TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade. Fujita S; Shimojo N; Terasaki F; Otsuka K; Hosotani N; Kohda Y; Tanaka T; Nishioka T; Yoshida T; Hiroe M; Kitaura Y; Ishizaka N; Imanaka-Yoshida K Heart Vessels; 2013 Sep; 28(5):646-57. PubMed ID: 23277455 [TBL] [Abstract][Full Text] [Related]
13. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. Sharma U; Rhaleb NE; Pokharel S; Harding P; Rasoul S; Peng H; Carretero OA Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1226-32. PubMed ID: 18178715 [TBL] [Abstract][Full Text] [Related]
14. Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats. Nakagawa P; Liu Y; Liao TD; Chen X; González GE; Bobbitt KR; Smolarek D; Peterson EL; Kedl R; Yang XP; Rhaleb NE; Carretero OA Am J Physiol Heart Circ Physiol; 2012 Nov; 303(9):H1114-27. PubMed ID: 22923621 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors: a new mechanism of action. Peng H; Carretero OA; Vuljaj N; Liao TD; Motivala A; Peterson EL; Rhaleb NE Circulation; 2005 Oct; 112(16):2436-45. PubMed ID: 16216963 [TBL] [Abstract][Full Text] [Related]
16. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension. González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875 [TBL] [Abstract][Full Text] [Related]
17. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis. Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498 [TBL] [Abstract][Full Text] [Related]
18. N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells. Kanasaki K; Koya D; Sugimoto T; Isono M; Kashiwagi A; Haneda M J Am Soc Nephrol; 2003 Apr; 14(4):863-72. PubMed ID: 12660320 [TBL] [Abstract][Full Text] [Related]
19. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats. Wang M; Liu R; Jia X; Mu S; Xie R Int J Mol Med; 2010 Dec; 26(6):795-801. PubMed ID: 21042772 [TBL] [Abstract][Full Text] [Related]